| First author and publication date | n | Hbtarget (g/dl) | Baseline Hb (g/dl) | Hb at end (g/dl) | Baseline creatinine (mg/dl) | Creatinine at end (mg/dl) | ||||
| Placebo | ESP | Placebo | ESP | Placebo | ESP | Placebo | ESP | |||
| Parissis, 200817 | 32 | 14.0 | 11.4 (0.7) | 11.0 (0.8) | 11.8 (1.3) | 12.8 (1.3) | 1.7 (0.4) | 1.8 (0.5) | N/A | N/A |
| Ghali, 20084 | 319 | 14.0 | 11.3 (10.7–11.9) | 11.5 (11.0–12.0) | Δ 0.5 (−0.3–1.2) | Δ 2.1 (1.3–2.8) | 1.4 (1.2–1.8) | 1.5 (1.1–1.9) | N/A | N/A |
| Van Veldhuisen, 20075 | 165 | 14.0 | 11.4 (0.9) | 11.5 (0.7) | 11.4 (1.4) | 13.3 (1.2) | 1.5 (0.6) | 1.4 (0.5) | 1.6 (0.8) | 1.3 (0.5) |
| Ponikowski, 200718 | 41 | 13.0–15.0 | 11.6 (0.2) | 11.8 (0.2) | 12.3 (0.4) | 13.9 (0.4) | 1.4 (0.5) | 1.3 (0.5) | 1.4 (0.4) | 1.2 (0.4) |
| Mancini, 200316 | 23 | Ht >45% | 10.9 (1.3) | 11.0 (0.6) | 11.5 (1.3) | 14.3 (1.2) | 1.6 (0.5) | 1.6 (0.4) | NA | NA |
| Palazzuoli, 20066 | 38 | 11.5–12.0 | 10.6 (0.7) | 10.4 (0.6) | 10.5 (0.6) | 12.4 (0.8) | 2.4 (0.6) | 2.5 (0.3) | 1.8 (0.4) | 2.2 (0.5) |
| Silverberg, 20017 | 32 | 12.5 | 10.9 (0.8) | 10.3 (1.2) | 10.8 (0.8) | 12.9 (1.1) | 1.4 (0.9) | 1.7 (0.8) | 1.8 (0.5) | 1.7 (0.7) |
Results are shown as mean (SD) or median (range).
ESP, erythropoietin-stimulating protein; Hb, haemoglobin.